Off-Target Effects of Psychoactive Drugs Revealed by Genome-Wide Assays in Yeast
Open Access
- 8 August 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Genetics
- Vol. 4 (8), e1000151
- https://doi.org/10.1371/journal.pgen.1000151
Abstract
To better understand off-target effects of widely prescribed psychoactive drugs, we performed a comprehensive series of chemogenomic screens using the budding yeast Saccharomyces cerevisiae as a model system. Because the known human targets of these drugs do not exist in yeast, we could employ the yeast gene deletion collections and parallel fitness profiling to explore potential off-target effects in a genome-wide manner. Among 214 tested, documented psychoactive drugs, we identified 81 compounds that inhibited wild-type yeast growth and were thus selected for genome-wide fitness profiling. Many of these drugs had a propensity to affect multiple cellular functions. The sensitivity profiles of half of the analyzed drugs were enriched for core cellular processes such as secretion, protein folding, RNA processing, and chromatin structure. Interestingly, fluoxetine (Prozac) interfered with establishment of cell polarity, cyproheptadine (Periactin) targeted essential genes with chromatin-remodeling roles, while paroxetine (Paxil) interfered with essential RNA metabolism genes, suggesting potential secondary drug targets. We also found that the more recently developed atypical antipsychotic clozapine (Clozaril) had no fewer off-target effects in yeast than the typical antipsychotics haloperidol (Haldol) and pimozide (Orap). Our results suggest that model organism pharmacogenetic studies provide a rational foundation for understanding the off-target effects of clinically important psychoactive agents and suggest a rational means both for devising compound derivatives with fewer side effects and for tailoring drug treatment to individual patient genotypes. Neuropsychiatric disorders such as depression and psychosis affect one-quarter of all individuals during their lifetime, and despite efforts to improve the selectivity of psychoactive drugs, all are associated with side effects. Drug efficacy and tolerance are known to be linked to an individual's genetic profile, but little is known about the nature of this correlation due, in part, to the current emphasis on screening compounds against targets in vitro. Here we present a comprehensive, genome-wide effort to understand drug effects on the cellular level using an unbiased genome-wide assay to determine the importance of every yeast gene for tolerance to 81 psychoactive drugs. We found that these medications perturbed many evolutionarily conserved genes and cellular pathways, such as those required for vesicle transport, establishment of cell polarity, and chromosome biology. The 500,000 drug–gene measurements obtained in this study increase our understanding of the mechanism of action of psychoactive drugs. Specifically, this study provides a framework to assess the next generation of psychoactive agents and to guide personalized medicine approaches that associate genotype and phenotype.This publication has 50 references indexed in Scilit:
- The Chemical Genomic Portrait of Yeast: Uncovering a Phenotype for All GenesScience, 2008
- Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug AdministrationPLoS Medicine, 2008
- Systematic pathway analysis using high-resolution fitness profiling of combinatorial gene deletionsNature Genetics, 2007
- A network of protein interactions determines polyglutamine toxicityProceedings of the National Academy of Sciences of the United States of America, 2006
- Flanking sequences profoundly alter polyglutamine toxicity in yeastProceedings of the National Academy of Sciences of the United States of America, 2006
- Telomere Length as a Quantitative Trait: Genome-Wide Survey and Genetic Mapping of Telomere Length-Control Genes in YeastPLoS Genetics, 2006
- Yeast as a tool to uncover the cellular targets of drugsBiotechnology Journal, 2006
- Global analysis of gene function in yeast by quantitative phenotypic profilingMolecular Systems Biology, 2006
- Genome-Wide Requirements for Resistance to Functionally Distinct DNA-Damaging AgentsPLoS Genetics, 2005
- Functional profiling of the Saccharomyces cerevisiae genomeNature, 2002